Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for BHC.TO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 35.18B
March 31, 2026 34.19B
December 31, 2025 36.14B
September 30, 2025 37.32B
June 30, 2025 37.20B
March 31, 2025 38.03B
December 31, 2024 38.15B
September 30, 2024 35.85B
June 30, 2024 36.25B
March 31, 2024 36.42B
December 31, 2023 36.06B
September 30, 2023 36.59B
June 30, 2023 33.75B
March 31, 2023 34.44B
December 31, 2022 34.80B
September 30, 2022 36.13B
June 30, 2022 36.34B
March 31, 2022 36.33B
December 31, 2021 36.89B
September 30, 2021 37.06B
June 30, 2021 37.20B
March 31, 2021 37.95B
December 31, 2020 39.75B
September 30, 2020 42.16B
June 30, 2020 42.76B
Date Value
March 31, 2020 45.36B
December 31, 2019 43.91B
September 30, 2019 41.93B
June 30, 2019 42.28B
March 31, 2019 43.49B
December 31, 2018 44.38B
September 30, 2018 43.66B
June 30, 2018 45.31B
March 31, 2018 46.15B
December 31, 2017 46.98B
September 30, 2017 49.99B
June 30, 2017 54.20B
March 31, 2017 56.46B
December 31, 2016 58.37B
September 30, 2016 60.14B
June 30, 2016 61.90B
March 31, 2016 63.40B
December 31, 2015 68.02B
September 30, 2015 64.96B
June 30, 2015 60.35B
March 31, 2015 48.84B
December 31, 2014 30.47B
September 30, 2014 30.24B
June 30, 2014 29.71B
March 31, 2014 30.89B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
HLS Therapeutics, Inc. 182.38M
Cipher Pharmaceuticals, Inc. 222.59M
BioSyent, Inc. 60.46M
Revive Therapeutics Ltd. 0.2818M
Knight Therapeutics, Inc. 1.045B

Total Assets (Quarterly) Related Metrics